Coeur Mining Inc (NYSE:CDE) announced preliminary first quarter production of 4.1 million ounces of silver and 58,836 ounces of gold, or 7.6 million silver equivalent ounces1. Coeur Mining Inc (NYSE:CDE) shares after opening at $9.27 moved to $9.40 on last trade day and at the end of the day closed at $9.10. Company price to sales ratio in past twelve months was calculated as 1.20 and price to cash ratio as 4.44. Coeur Mining Inc (NYSE:CDE) showed a negative weekly performance of -2.05%.
Investors in Array Biopharma Inc (NASDAQ:ARRY) saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARRY options chain for the new May 17th contracts and identified the following call contract of particular interest. Array Biopharma Inc (NASDAQ:ARRY) shares advanced 1.92% in last trading session and ended the day on $4.25. ARRY return on equity ratio is recorded as 307.40% and its return on assets is -52.70%. Array Biopharma Inc (NASDAQ:ARRY) yearly performance is -15.00%.
Castlight Health (NASDAQ:CSLT)‘s stock had its “buy” rating reaffirmed by research analysts at Stifel Nicolaus in a report released on Tuesday, Analyst Ratings.Net reports. They currently have a $24.00 price target on the stock. Stifel Nicolaus’ price target points to a potential upside of 23.14% from the company’s current price. Castlight Health Inc (NYSE:CSLT) shares moved down -9.64% in last trading session and was closed at $19.49, while trading in range of $19.31-$21.96. Castlight Health Inc (NYSE:CSLT) year to date performance is -51.03%.
Antares Pharma (NASDAQ:ATRS) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its disappointing return on equity, generally disappointing historical performance in the stock itself and deteriorating net income. Antares Pharma Inc (NASDAQ:ATRS) weekly performance is -5.14%. On last trading day company shares ended up $3.32. Antares Pharma Inc (NASDAQ:ATRS) distance from 50-day simple moving average is -22.02%. Analysts mean target price for the company is $6.30.